Learn more

ASSIST PUBL HOPITAUX MARSEILLE

Overview
  • Total Patents
    25
About

ASSIST PUBL HOPITAUX MARSEILLE has a total of 25 patent applications. Its first patent ever was published in 2009. It filed its patents most often in WIPO (World Intellectual Property Organization), France and EPO (European Patent Office). Its main competitors in its focus markets biotechnology, measurement and pharmaceuticals are APTAMER SCIENCES INC, CT LEON BERARD and AMDL INC.

Patent filings in countries

World map showing ASSIST PUBL HOPITAUX MARSEILLEs patent filings in countries

Patent filings per year

Chart showing ASSIST PUBL HOPITAUX MARSEILLEs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Raoult Didier 18
#2 Rolain Jean-Marc 6
#3 Drancourt Michel 6
#4 Brunel Jean-Michel 5
#5 Piarroux Renaud 2
#6 Cassagne Carole 2
#7 Mege Jean-Louis 2
#8 Bregeon Fabienne 2
#9 Iovanna Juan 2
#10 Fardeau Marie-Laure 2

Latest patents

Publication Filing date Title
FR3009089A1 Method of analysis of biological sample by subtracting the respective total areas of a mass spectrum of a sample to be analyzed and a reference spectrum
WO2013150204A1 Method for determining the tumoral or non-tumoral nature, or the tumor type, of a solid human or animal organ fragment
WO2013110891A1 Use of an acellular empirical culture medium for the growth of intracellular bacteria
WO2013004933A1 Culturing and detection of a methanogenic archaeon
FR2990954A1 New Archaea Methanomassiliicoccus luminyensis isolated and established in culture, comprising 16S ribosomal DNA gene-specific sequence or a complementary sequence, useful for diagnostic purposes
FR2990697A1 Method of attenuating a bacterium of the mycobacterium tuberculosis complex for the manufacture of a vaccine against tuberculosis
FR2985668A1 USE OF SQUALAMINE OR THE LIKE AS DISINFECTANT
FR2977589A1 Culture and detection of a methanogenic archaea
FR2967691A1 Method for identifying a fungus, in particular a filamentous fungus, and uses
US2013011392A1 Method for assessing the ability of a patient to respond to or be safely treated by a nucleoside analog based-chemotherapy
EP2441836A1 Compound inhibiting TP53INP1 activity for the treatment of prostate cancer, and its use in screening and diagnostic methods
FR2961311A1 Method for identification of eukaryotic cells by maldi-tof mass spectrometry
EP2383572A1 Cellular humoral activation test (CHAT)
FR2956905A1 Method for identifying the animal species of the origin of the proteins contained in a sample to be tested
FR2953530A1 Method for rapid identification of viruses by mass spectrometry
FR2953138A1 AMINOSTEROIDAL COMPOUNDS FOR LOCAL TOPICAL APPLICATION FOR CUTANEO-MUCOUS DECOLONIZATION OF STAPHYLOCOCCUS AUREUS